Imaging Studies and the Development of Multiple Myeloma

NCT01571726 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Multiple Myeloma
Smoldering Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance

Interventions

DRUG: Fluciclatide

Sponsor

National Cancer Institute (NCI)